Solventum Corporation

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Solventum Corp reports growth amidst challenges, eyes future profitability

Solventum Corporation is navigating challenges while capitalizing on strengths to drive growth.
The company's strategic focus on stabilizing, growing, and optimizing its business bodes well for the future.
Investors should watch for updates on Phase 2 progress and strategic portfolio decisions in the upcoming quarters.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Solventum Corp. operates as a health care company. The company was founded on January 24, 2023 and is headquartered in Maplewood, MN.

ST. PAUL, Minn. , Aug. 28, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) executives plan to participate in the following investor conferences: 2024 Wells Fargo Healthcare Conference in Everett, MA on Wednesday, September 4, 2024 at 11:00 a.m.

Solventum to Participate in Upcoming Investor Conferences

Chimera Investment

MDU Resources Group

Paramount Global

I sold Chimera. They were an underperforming REIT, even on their best days. I actually have received total proceeds of $10,967 and have recognized a total gain of $1,090.40. Warner Bro. Discovery, as my unrealized loss right now, is $1,600.

Lanny's Stock Sales Through June 30, 2024

ST. PAUL, Minn., Aug. 20, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV), formerly 3M Health Care, today announced that its autonomous coding solution has received Toolbox designation from Epic in the Fully Autonomous Coding category.

Solventum autonomous coding listed in Epic Toolbox

Solventum's (SOLV) second-quarter results show resilience in MedSurg and Health Information Systems. Its shrinking margins pose concerns.

Solventum's (SOLV) Q2 Earnings Beat Estimates, ' 24 View Raised

Solventum Corporation (NYSE:SOLV ) Q2 2024 Earnings Call August 8, 2024 4:30 PM ET Company Participants Kevin Moran - Senior Vice President, Investor Relations Bryan Hanson - Chief Executive Officer Wayde McMillan - Chief Financial Officer Conference Call Participants Travis Steed - Bank of America Vik Chopra - Wells Fargo David Roman - Goldman Sachs Operator Good day. My name is Ellie, and I will be your conference operator for today.

Solventum Corporation (SOLV) Q2 2024 Earnings Call Transcript

3M spin-off Solventum's second-quarter profit fell more than 70% on Thursday, hurt by limited sales growth of its wound care and surgical sterilization products and higher expenses, as it navigates functioning as a newly independent company.

Solventum's second-quarter profit falls 70% on higher expenses

Separation activities and business continuity on track Reported sales increased 0.2% to $2.081 billion; organic sales increased 1.3% GAAP Earnings Per Share (EPS) of $0.51; adjusted EPS1 of $1.56 Generated $355 million in cash from operations; free cash flow1 of $297 million Raises full-year 2024 organic sales growth and adjusted EPS guidance ST. PAUL, Minn.

Solventum Reports Second Quarter 2024 Financial Results and Raises Full-Year Guidance

Enhabit Inc

V.F.

We were more active than usual in the quarter, buying shares that were available at very attractive prices. All in, we have ugly ducklings - high returns on capital, cash cow spinoffs, working through resolvable issues, and selling at attractive prices. I love buying businesses like this, and if it drops to my next buy price, we will add to it.

Curreen Capital: Ugly Ducklings Selling At An Attractive Price

Since its spinoff from 3M, Solventum has been under-covered and misunderstood by the market.

Activist Trian has a few levers to pull to build shareholder value at Solventum

D.R. Horton

Pool

It's been a rough couple of weeks for the Magnificent Seven stocks. But it's been a boon for some other S&P 500 stocks.

11 Stocks Now Thrive As The Magnificent Seven Fall Apart

Solventum (NYSE: SOLV ) stock is up on Tuesday after activist investor Trian Capital took a stake in the healthcare company. According to insider sources, Trian Capital has taken a large stake in the company.

SOLV Stock Alert: Solventum Pops as Activist Investor Trian Capital Takes Stake

Solventum (NYSE: SOLV ) stock is up on Tuesday after activist investor Trian Fund Management took a stake in the healthcare company. According to insider sources, Trian has taken a large stake in the company.

SOLV Stock Alert: Solventum Pops as Activist Investor Trian Takes Stake

The move comes just months after 3M spun off the healthcare product company.

Solventum Stock Jumps as Activist Trian Discloses Stake

Activist investor Nelson Peltz's Trian Fund Management has built a stake in 3M's healthcare spinoff Solventum , Bloomberg News reported on Monday, citing people with knowledge of the matter, sending shares of the company up 3.4% after the bell.

Nelson Peltz's Trian said to build stake in 3M spinoff Solventum, Bloomberg News reports

ST. PAUL, Minn., July 16, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) will release its second quarter 2024 financial results on Thursday, August 8, 2024 after the U.S. financial markets close.

Solventum to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024

ST. PAUL, Minn., July 2, 2024 /PRNewswire/ -- Solventum today announced that U.S. News & World Report is expanding its use of Solventum's  3M™ Ambulatory Potentially Preventable Complications  (AM-PPCs) software in the analysis of its 2024-2025 Best Hospitals rankings.

U.S. News & World Report Expands Use of Solventum's Ambulatory Potentially Preventable Complications Grouping Software for Use in Its 2024-2025 Best Hospitals Rankings

ST. PAUL, Minn., June 24, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV), [formerly 3M Health Care] today announced a new artificial intelligence (AI)-driven payment integrity and revenue cycle solution, Solventum™ Revenue Integrity System.

Solventum introduces denials prevention solution, an AI-powered tool, empowering health systems to help reduce write-offs and improve top line revenue

Archer-Daniels-Midland Company

Palantir Technologies

Wall Street loves winners. They enjoy backing stocks that are rising and want to avoid stocks that are falling.

Contrarian Plays: 3 Stocks to Buy When Analysts Say ‘Sell'

Despite the strong rally recently, I see more upside for 3M Company stock prices. The top drivers include the Solventum Corporation spin-off and the settlement of its legacy lawsuits, both enhancing the clarity of its growth curve ahead. The attractive valuation multiples add further upside potential.

3M Company: Solventum Spinoff Creates More Upside Potential

ST. PAUL, Minn., June 7, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) has been notified that TRC Capital Investment Corporation ("TRC") made an unsolicited "mini-tender offer" to purchase up to 2,000,000 shares of the company's common stock at $59.15 per share and decreased the offer price on June 6, 2024, to $55.00 per share.

Solventum Cautions Investors Regarding TRC Capital's "Mini-Tender Offer"

TORONTO, June 06, 2024 (GLOBE NEWSWIRE) -- TRC Capital Investment Corporation (TRC) announced today that based on current market conditions, TRC has amended the terms of its tender offer for up to 2,000,000 common shares of Solventum Corporation (the Company) and has decreased the offer price payable to US$55.00 per share from US$59.15 per share.

TRC Amends Its Tender Offer for Solventum Corporation

WK Kellogg Co

Kenvue

Too often spinoff stocks don't perform well out of the gate. Because an investor bought the business of the parent company, he doesn't care too much about whatever side project is being shed.

Divide and Conquer: 3 Stock Spinoffs Set to Trounce the Market

Brookfield Renewable Partners

Canadian Natural Resources

Enbridge

Enterprise Products Partners

IonQ

JPMorgan Equity Premium Income ETF

Lithium Americas Corp

Defiance Nasdaq 100 Enhanced Options Income ETF

QuantumScape

Tilray Brands

VictoryShares Free Cash Flow ETF

The "Undercovered" Dozen highlights twelve ideas from the previous month on stocks with limited coverage. QuantumScape, IonQ, Enbridge preferred shares, Tilray, and more are included this month.

The 'Undercovered' Dozen From April 2024

3M healthcare spinoff Solventum says it will prioritize paying back debt over dividends and share buybacks for the next 24 months.

Solventum Reports Earnings. There Will Be No Dividend.

Completed spin-off from 3M and began trading on April 1, 2024 Reported sales increased 0.2% to $2.016 billion, organic sales increased 0.9% GAAP Earnings Per Share (EPS) of $1.37; adjusted EPS1 of $2.08 Generated $442 million in cash from operations; free cash flow1 of $340 million Reaffirms full-year 2024 guidance ST. PAUL, Minn.

News for Solventum Corporation Stock (SOLV)